{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:56Z","timestamp":1790168456143,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82371574"],"award-info":[{"award-number":["No. 82371574"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82370446"],"award-info":[{"award-number":["No. 82370446"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04367-9","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:54:14Z","timestamp":1777895654000},"page":"4346-4358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4218-946X","authenticated-orcid":false,"given":"Shuzhen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meitong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"4367_CR1","volume":"51","author":"H Wang","year":"2024","unstructured":"Wang H, Yu X, Guo J, Ma S, Liu Y, Hu Y, et al. Burden of cardiovascular disease among the western pacific region and its association with human resources for health, 1990\u20132021: a systematic analysis of the global burden of disease study 2021. Lancet Reg Health: West Pac. 2024;51:101195.","journal-title":"Lancet Reg Health: West Pac"},{"issue":"38","key":"4367_CR2","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","volume":"45","author":"A Timmis","year":"2024","unstructured":"Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A,\u00a0Kavousi M,\u00a0et al. European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics. Eur Heart J. 2024;45(38):4019\u201362.","journal-title":"Eur Heart J"},{"issue":"11","key":"4367_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","volume":"32","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R,\u00a0Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2025;32(11):1001\u201315.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"4367_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4367_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"4367_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2468-1253(19)30345-0","volume":"4","author":"S Safiri","year":"2019","unstructured":"GBD 2017 Colorectal Cancer Collaborators. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913\u201333.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4367_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/CLEP.S472553","volume":"16","author":"D Jiang","year":"2024","unstructured":"Jiang D, Wu Y, Liu L, Shen Y, Li T, Lu Y, et al. Burden of gastrointestinal tumors in Asian countries, 1990\u20132021: an analysis for the global burden of disease study 2021. Clin Epidemiol. 2024;16:587\u2013601.","journal-title":"Clin Epidemiol"},{"issue":"18","key":"4367_CR8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/CM9.0000000000003277","volume":"137","author":"Z Cheng","year":"2024","unstructured":"Cheng Z, Wang T, Jiao Y, Qi J, Zhang X, Zhou S, et al. Burden of digestive system diseases in China and its provinces during 1990\u20132019: results of the 2019 global disease burden study. Chin Med J. 2024;137(18):2182\u20139.","journal-title":"Chin Med J"},{"issue":"2","key":"4367_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaccao.2024.11.004","volume":"7","author":"SH Johansen","year":"2025","unstructured":"Johansen SH, Wisl\u00f8ff T, Edvardsen E, Kollerud ST, Jensen JSS, Agwu G, et al. Effects of systemic anticancer treatment on cardiorespiratory fitness. JACC CardioOncol. 2025;7(2):96\u2013106.","journal-title":"JACC CardioOncol"},{"key":"4367_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2021.02.003","volume":"87","author":"SP Whelton","year":"2021","unstructured":"Whelton SP, Berning P, Blumenthal RS, Marshall CH, Martin SS, Mortensen MB,\u00a0et al. Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease. Eur J Intern Med. 2021;87:3\u201312.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"4367_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaccao.2022.03.004","volume":"4","author":"NML Battisti","year":"2022","unstructured":"Battisti NML, Welch CA, Sweeting M, de Belder M, Deanfield J, Weston C, et al. Prevalence of cardiovascular disease in patients with potentially curable malignancies. JACC CardioOncol. 2022;4(2):238\u201353.","journal-title":"JACC CardioOncol"},{"issue":"9","key":"4367_CR12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.mayocp.2020.05.044","volume":"95","author":"A Guha","year":"2020","unstructured":"Guha A, Dey AK, Kalra A, Gumina R, Lustberg M, Lavie CJ, et al. Coronary artery bypass grafting in cancer patients. Mayo Clin Proc. 2020;95(9):1865\u201376.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"4367_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","volume":"21","author":"RA De Boer","year":"2019","unstructured":"de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019;21(12):1515\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4367_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/bs.pmbts.2022.07.012","volume":"192","author":"MJ Alam","year":"2022","unstructured":"Alam MJ, Puppala V, Uppulapu SK, Das B, Banerjee SK. Human microbiome and cardiovascular diseases. Prog Mol Biol Transl Sci. 2022;192(1):231\u201379.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"6","key":"4367_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurheartj\/eht331","volume":"35","author":"AM Van Der Laan","year":"2014","unstructured":"van der Laan AM, Ter Horst EN, Delewi R, Begieneman MP, Krijnen PA, Hirsch A, et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35(6):376\u201385.","journal-title":"Eur Heart J"},{"issue":"7","key":"4367_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.118.035516","volume":"138","author":"CE Handy","year":"2018","unstructured":"Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, et al. Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger. Circulation. 2018;138(7):727\u201334.","journal-title":"Circulation"},{"key":"4367_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.atherosclerosis.2017.06.001","volume":"263","author":"F Masoudkabir","year":"2017","unstructured":"Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, et al. Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017;263:343\u201351.","journal-title":"Atherosclerosis"},{"issue":"11","key":"4367_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104\u201314.","journal-title":"Circulation"},{"issue":"21","key":"4367_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010052","volume":"7","author":"M Sotos-Prieto","year":"2018","unstructured":"Sotos-Prieto M, Mattei J, Cook NR, Hu FB, Willett WC, Chiuve SE, et al. Association between a 20-year cardiovascular disease risk score based on modifiable lifestyles and total and cause-specific mortality among US men and women. J Am Heart Assoc. 2018;7(21):e010052.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"4367_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05328-0","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo H, Zhuang K, Ding N, Hua R, Tang H, Wu Y, et al. High-fat diet induced cyclophilin B enhances STAT3\/lncRNA-PVT1 feedforward loop and promotes growth and metastasis in colorectal cancer. Cell Death Dis. 2022;13(10):883.","journal-title":"Cell Death Dis"},{"issue":"6556","key":"4367_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aba3683","volume":"373","author":"W Yoo","year":"2021","unstructured":"Yoo W, Zieba JK, Foegeding NJ, Torres TP, Shelton CD, Shealy NG, et al. High-fat diet\u2013induced colonocyte dysfunction escalates microbiota-derived trimethylamine N -oxide. Science. 2021;373(6556):813\u20138.","journal-title":"Science"},{"key":"4367_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111762","volume":"160","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu M, Sun X, Shi H, Zhu J. Green tea extract alters gut microbiota and their metabolism of adults with metabolic syndrome in a host-free human colonic model. Food Res Int. 2022;160:111762.","journal-title":"Food Res Int"},{"issue":"2","key":"4367_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.critrevonc.2010.01.010","volume":"74","author":"R Labianca","year":"2010","unstructured":"Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106\u201333.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4367_CR24","doi-asserted-by":"publisher","DOI":"10.34172\/ipp.2022.34421","volume":"10","author":"G Abangah","year":"2022","unstructured":"Abangah G, Sarokhani D, Abdan Z, Fakhri M, Nourmohammadi H. The effect of metformin use on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis of cohort studies. Immunopathologia Persa. 2022;10(1):e34421.","journal-title":"Immunopathologia Persa"},{"issue":"3","key":"4367_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1152\/physrev.2001.81.3.1031","volume":"81","author":"DL Topping","year":"2001","unstructured":"Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81(3):1031\u201364.","journal-title":"Physiol Rev"},{"issue":"2","key":"4367_CR26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/ijms13021524","volume":"13","author":"G Riccioni","year":"2012","unstructured":"Riccioni G, Sblendorio V, Gemello E, Di Bello B, Scotti L, Cusenza S, et al. Dietary fibers and cardiometabolic diseases. Int J Mol Sci. 2012;13(2):1524\u201340.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4367_CR27","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1039\/D1FO03094A","volume":"13","author":"YZ Li","year":"2022","unstructured":"Li YZ, Yang ZY, Gong TT, Liu YS, Liu FH, Wen ZY, et al. Cruciferous vegetable consumption and multiple health outcomes: an umbrella review of 41 systematic reviews and meta-analyses of 303 observational studies. Food Funct. 2022;13(8):4247\u201359.","journal-title":"Food Funct"},{"key":"4367_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125298","volume":"268","author":"G Fan","year":"2024","unstructured":"Fan G, Zhang B, Wang J, Wang N, Qin S, Zhao W, et al. Accurate construction of NIR probe for visualizing HClO fluctuations in type I, type II diabetes and diabetic liver disease assisted by theoretical calculation. Talanta. 2024;268:125298.","journal-title":"Talanta"},{"issue":"15","key":"4367_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158250","volume":"25","author":"C Munteanu","year":"2024","unstructured":"Munteanu C, Schwartz B. Interactions between dietary antioxidants, dietary fiber and the gut microbiome: their putative role in inflammation and cancer. Int J Mol Sci. 2024;25(15):8250.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4367_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12937-020-00556-6","volume":"19","author":"XF Zhang","year":"2020","unstructured":"Zhang XF, Wang XK, Tang YJ, Guan XX, Guo Y, Fan JM, et al. Association of whole grains intake and the risk of digestive tract cancer: a systematic review and meta-analysis. Nutr J. 2020;19(1):52.","journal-title":"Nutr J"},{"issue":"21","key":"4367_CR31","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1080\/10408398.2023.2187212","volume":"64","author":"A Liang","year":"2024","unstructured":"Liang A, Leonard W, Beasley JT, Fang Z, Zhang P, Ranadheera CS. Anthocyanins\u2013gut microbiota\u2013health axis: a review. Crit Rev Food Sci Nutr. 2024;64(21):7563\u201388.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4367_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2023.113182","volume":"172","author":"LA Bello-Perez","year":"2023","unstructured":"Bello-Perez LA, Flores-Silva PC. Interaction between starch and dietary compounds: new findings and perspectives to produce functional foods. Food Res Int. 2023;172:113182.","journal-title":"Food Res Int"},{"issue":"8","key":"4367_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-019-00523-4","volume":"34","author":"L Schwingshackl","year":"2019","unstructured":"Schwingshackl L, Kn\u00fcppel S, Michels N, Schwedhelm C, Hoffmann G, Iqbal K, et al. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries. Eur J Epidemiol. 2019;34(8):765\u201375.","journal-title":"Eur J Epidemiol"},{"issue":"13","key":"4367_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/bjsports-2021-105061","volume":"56","author":"H Momma","year":"2022","unstructured":"Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med. 2022;56(13):755\u201363.","journal-title":"Br J Sports Med"},{"issue":"24","key":"4367_CR35","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/bjsports-2020-102587","volume":"54","author":"B Cillekens","year":"2020","unstructured":"Cillekens B, Lang M, van Mechelen W, Verhagen E, Huysmans MA, Holtermann A, et al. How does occupational physical activity influence health? An umbrella review of 23 health outcomes across 158 observational studies. Br J Sports Med. 2020;54(24):1474\u201381.","journal-title":"Br J Sports Med"},{"issue":"15","key":"4367_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bjsports-2022-105669","volume":"57","author":"L Garcia","year":"2023","unstructured":"Garcia L, Pearce M, Abbas A, Mok A, Strain T, Ali S, et al. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose\u2013response meta-analysis of large prospective studies. Br J Sports Med. 2023;57(15):979\u201389.","journal-title":"Br J Sports Med"},{"key":"4367_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118392","volume":"260","author":"LG Fernandes","year":"2020","unstructured":"Fernandes LG, Tobias GC, Paix\u00e3o AO, Dourado PM, Voltarelli VA, Brum PC. Exercise training delays cardiac remodeling in a mouse model of cancer cachexia. Life Sci. 2020;260:118392.","journal-title":"Life Sci"},{"issue":"3","key":"4367_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/1470320319895646","volume":"21","author":"X Chen","year":"2020","unstructured":"Chen X, Yi CH, Ya KG. Renin\u2013angiotensin system inhibitor use and colorectal cancer risk and mortality: a dose\u2013response meta-analysis. J Renin Angiotensin Aldosterone Syst. 2020;21(3):1470320319895646.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"8","key":"4367_CR39","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1089\/ars.2010.3792","volume":"15","author":"J Lu","year":"2011","unstructured":"Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal. 2011;15(8):2301\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"4-6","key":"4367_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","volume":"32","author":"BM Hybertson","year":"2011","unstructured":"Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32(4\u20136):234\u201346.","journal-title":"Mol Aspects Med"},{"key":"4367_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03271-w","author":"M Tozzi","year":"2025","unstructured":"Tozzi M, Fiore A, Travaglione S, Marcon F, Rainaldi G, Germinario EAP, et al. E. coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration. J Exp Clin Cancer Res.\u00a02025 Jan 29;44(1):29.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4367_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12229","volume":"16","author":"S O\u2019Neill","year":"2014","unstructured":"O\u2019Neill S, O\u2019Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2014;16(1):1\u201312.","journal-title":"Obes Rev"},{"issue":"6","key":"4367_CR43","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/gutjnl-2020-321661","volume":"70","author":"H Chen","year":"2021","unstructured":"Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, et al. Metabolic syndrome, metabolic comorbid conditions and risk of early onset colorectal cancer. Gut. 2021;70(6):1147\u201354.","journal-title":"Gut"},{"issue":"12","key":"4367_CR44","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jama.298.12.1412","volume":"298","author":"AOO Chan","year":"2007","unstructured":"Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007;298(12):1412.","journal-title":"JAMA"},{"issue":"5","key":"4367_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/1751-2980.12243","volume":"16","author":"XB Yang","year":"2015","unstructured":"Yang XB, Xu QL, Xu CY, Wu C, Yu LF. Prevalence of colorectal neoplasm in Chinese patients with high-risk coronary artery disease classified by the Asia\u2013Pacific colorectal screening score. J Dig Dis. 2015;16(5):272\u20138.","journal-title":"J Dig Dis"},{"issue":"1","key":"4367_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12967-023-04803-2","volume":"22","author":"T Attachaipanich","year":"2024","unstructured":"Attachaipanich T, Chattipakorn SC, Chattipakorn N. Current evidence regarding the cellular mechanisms associated with cancer progression due to cardiovascular diseases. J Transl Med. 2024;22(1):105.","journal-title":"J Transl Med"},{"issue":"22","key":"4367_CR47","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.123.066911","volume":"149","author":"T Caller","year":"2024","unstructured":"Caller T, Rotem I, Shaihov-Teper O, Lendengolts D, Schary Y, Shai R, et al. Small extracellular vesicles from infarcted and failing heart accelerate tumor growth. Circulation. 2024;149(22):1729\u201348.","journal-title":"Circulation"},{"issue":"12","key":"4367_CR48","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cgh.2010.08.010","volume":"8","author":"DJ Robertson","year":"2010","unstructured":"Robertson DJ, Riis AH, Friis S, Pedersen L, Baron JA, S\u00f8rensen HT. Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer. Clin Gastroenterol Hepatol. 2010;8(12):1056\u201361.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"4367_CR49","first-page":"511","volume":"38","author":"A Xiaolan","year":"2018","unstructured":"Ai XL, Yao F, Wang XJ, Duan DB, Li K, Hu ZY, et al. Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(5):511\u20139.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"3","key":"4367_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/cvr\/cvr309","volume":"93","author":"LM Berglund","year":"2011","unstructured":"Berglund LM, Kotova O, Osmark P, Grufman H, Xing C, Lydrup ML, et al. NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis. Cardiovasc Res. 2011;93(3):414\u201323.","journal-title":"Cardiovasc Res"},{"issue":"21","key":"4367_CR51","doi-asserted-by":"publisher","first-page":"12045","DOI":"10.1073\/pnas.2131556100","volume":"100","author":"P Tangvoranuntakul","year":"2003","unstructured":"Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A. 2003;100(21):12045\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4367_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-3089.2011.00622.x","volume":"18","author":"V Padler-Karavani","year":"2011","unstructured":"Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation. 2011;18(1):1\u20135.","journal-title":"Xenotransplantation"},{"issue":"5","key":"4367_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"5","key":"4367_CR54","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635\u201345.","journal-title":"Cell Metab"},{"issue":"11","key":"4367_CR55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759\u201371.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4367_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197464","volume":"13","author":"AN Samraj","year":"2018","unstructured":"Samraj AN, Bertrand KA, Luben R, Khedri Z, Yu H, Nguyen D, et al. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: total antibody levels are associated with colorectal cancer risk. PLoS ONE. 2018;13(6):e0197464.","journal-title":"PLoS ONE"},{"issue":"12","key":"4367_CR57","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/ajg.2009.574","volume":"104","author":"H Singh","year":"2009","unstructured":"Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN. Long-term use of statins and risk of colorectal cancer: a population-based study. Am J Gastroenterol. 2009;104(12):3015\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"4367_CR58","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1517\/14728222.2011.647810","volume":"16","author":"D Avivi","year":"2012","unstructured":"Avivi D, Moshkowitz M, Detering E, Arber N. The role of low-dose aspirin in the prevention of colorectal cancer. Expert Opin Ther Targets. 2012;16(Suppl 1):S51\u201362.","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"4367_CR59","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10654-023-01024-1","volume":"38","author":"L Emilsson","year":"2023","unstructured":"Emilsson L, Song M, Ludvigsson JF. Target trial emulation of aspirin after diagnosis of colorectal polyps. Eur J Epidemiol. 2023;38(10):1105\u201314.","journal-title":"Eur J Epidemiol"},{"key":"4367_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102426","volume":"55","author":"H Chen","year":"2022","unstructured":"Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R, et al. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR\/SREBP-1\/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol. 2022;55:102426.","journal-title":"Redox Biol"},{"issue":"7","key":"4367_CR61","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jchf.2023.10.003","volume":"12","author":"KP Shah","year":"2024","unstructured":"Shah KP, Khan SS, Baldridge AS, Grady KL, Cella D, Goyal P, et al. Health status in heart failure and cancer: analysis of the medicare health outcomes survey 2016\u20132020. JACC Heart Fail. 2024;12(7):1166\u201378.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"4367_CR62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","volume":"3","author":"ES Lau","year":"2021","unstructured":"Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48\u201358.","journal-title":"JACC CardioOncol"},{"issue":"7","key":"4367_CR63","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","volume":"138","author":"WC Meijers","year":"2018","unstructured":"Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, et al. Heart failure stimulates tumor growth by circulating factors. Circulation. 2018;138(7):678\u201391.","journal-title":"Circulation"},{"issue":"6","key":"4367_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2025.103034","volume":"50","author":"AK Siddiqi","year":"2025","unstructured":"Siddiqi AK, Shahzad M, Maniya MT, Chachar MA, Saleem N, Garcia M, et al. Shifting trends and disparities in colorectal cancer and heart failure-related mortality in the United States: a two-decade retrospective analysis. Curr Probl Cardiol. 2025;50(6):103034.","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"4367_CR65","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jaccao.2023.08.003","volume":"5","author":"FN Salloum","year":"2023","unstructured":"Salloum FN, Tocchetti CG, Ameri P, Ardehali H, Asnani A, de Boer RA, et al. Priorities in cardio-oncology basic and translational science. JACC CardioOncol. 2023;5(6):715\u201331.","journal-title":"JACC CardioOncol"},{"issue":"6","key":"4367_CR66","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cvr\/cvae038","volume":"120","author":"S De Wit","year":"2024","unstructured":"de Wit S, Geerlings L, Shi C, Dronkers J, Schouten EM, Blancke G, et al. Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice. Cardiovasc Res. 2024;120(6):612\u201322.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"4367_CR67","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/cells11071108","volume":"11","author":"L Awwad","year":"2022","unstructured":"Awwad L, Goldenberg T, Langier-Goncalves I, Aronheim A. Cardiac remodeling in the absence of cardiac contractile dysfunction is sufficient to promote cancer progression. Cells. 2022;11(7):1108.","journal-title":"Cells"},{"issue":"1","key":"4367_CR68","first-page":"C106","volume":"320","author":"A S\u00e1nchez-Navarro","year":"2021","unstructured":"S\u00e1nchez-Navarro A, Gonz\u00e1lez-Soria I, Caldi\u00f1o-Bohn R, Bobadilla NA. An integrative view of serpins in health and disease: the contribution of SerpinA3. Am J Physiol Cell Physiol. 2021;320(1):C106\u201318.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"21","key":"4367_CR69","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.jacc.2020.03.067","volume":"75","author":"VN Msce","year":"2020","unstructured":"Narayan V, Thompson EW, Demissei B, Ho JE, Januzzi JL Jr, Ky B. Mechanistic biomarkers informative of both cancer and cardiovascular disease. J Am Coll Cardiol. 2020;75(21):2726\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4367_CR70","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.6004\/jnccn.2022.7042","volume":"20","author":"SF Lee","year":"2022","unstructured":"Lee SF, Yip PL, Vellayappan BA, Chee CE, Wong LC, Wan EY, et al. Incident cardiovascular diseases among survivors of high-risk stage II\u2013III colorectal cancer: a cluster-wide cohort study. J Natl Compr Canc Netw. 2022;20(10):1125-1133.e10.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"4367_CR71","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2017.74.9739","volume":"36","author":"KM Kenzik","year":"2018","unstructured":"Kenzik KM, Balentine C, Richman J, Kilgore M, Bhatia S, Williams GR. New-onset cardiovascular morbidity in older adults with stage I\u2013III colorectal cancer. J Clin Oncol. 2018;36(6):609\u201316.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4367_CR72","doi-asserted-by":"publisher","first-page":"797","DOI":"10.21037\/jgo.2019.03.04","volume":"10","author":"K Keramida","year":"2019","unstructured":"Keramida K, Charalampopoulos G, Filippiadis D, Tsougos E, Farmakis D. Cardiovascular complications of metastatic colorectal cancer treatment. J Gastrointest Oncol. 2019;10(4):797\u2013806.","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"4367_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-020-2675-x","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Ma L, Xu Y, Liu Y, Li W, Cai J. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-\u03baB\/STAT3-regulated proteins. Cell Death Dis. 2020;11(6):477.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4367_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29929","volume":"10","author":"W Huang","year":"2024","unstructured":"Huang W, Xu S, Zhou H, Ji W, Chen Y. Global association of incidence between atrial fibrillation and the major gastrointestinal cancers: an analysis based on the 2019 global burden of disease study. Heliyon. 2024;10(9):e29929.","journal-title":"Heliyon"},{"issue":"1","key":"4367_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ejhf.2059","volume":"23","author":"MS Anker","year":"2021","unstructured":"Anker MS, von Haehling S, Coats AJS, Riess H, Eucker J, Porthun J, et al. Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study. Eur J Heart Fail. 2021;23(1):145\u201353.","journal-title":"Eur J Heart Fail"},{"key":"4367_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3775","author":"P Ameri","year":"2025","unstructured":"Ameri P, Costa P, Benson L, Stolfo D, Sayour NV, Ljungman C, et al. Characteristics and outcomes of patients with heart failure and history of malignancy: data from Swedish Heart Failure Registry and the National Cancer Register. Eur J Heart Fail.\u00a02025 Nov;27(11):2116-2129.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4367_CR77","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","volume":"144","author":"MG Fradley","year":"2021","unstructured":"Fradley MG, Beckie TM, Brown SA, Cheng RK, Dent SF, Nohria A, et al. Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e41\u201355.","journal-title":"Circulation"},{"issue":"38","key":"4367_CR78","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1093\/eurheartj\/ehab362","volume":"42","author":"JE Salem","year":"2021","unstructured":"Salem JE, Nguyen LS, Moslehi JJ, Ederhy S, Lebrun-Vignes B, Roden DM, et al. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study. Eur Heart J. 2021;42(38):3915\u201328.","journal-title":"Eur Heart J"},{"issue":"4","key":"4367_CR79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.amjcard.2019.05.029","volume":"124","author":"MG Fradley","year":"2019","unstructured":"Fradley MG, Gliksman M, Emole J, Viganego F, Rhea I, Welter-Frost A, et al. Rates and risk of atrial arrhythmias in patients treated with ibrutinib compared with cytotoxic chemotherapy. Am J Cardiol. 2019;124(4):539\u201344.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4367_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ehjcvp\/pvaa037","volume":"7","author":"J Alexandre","year":"2020","unstructured":"Alexandre J, Salem JE, Moslehi J, Sassier M, Ropert C, Cautela J, et al. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database. Eur Heart J Cardiovasc Pharmacother. 2020;7(4):312\u201320.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"12","key":"4367_CR81","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007724","volume":"6","author":"A Porta-Sanchez","year":"2017","unstructured":"Porta-S\u00e1nchez A, Gilbert C, Spears D, Amir E, Chan J, Nanthakumar K, et al. Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc. 2017;6(12):e007724.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"4367_CR82","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/jcmm.12467","volume":"19","author":"L Liu","year":"2015","unstructured":"Liu L, Zheng Q, Lee J, Ma Z, Zhu Q, Wang Z. PD-1\/PD-L1 expression on CD4+ T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation. J Cell Mol Med. 2015;19(6):1223\u201333.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4367_CR83","doi-asserted-by":"publisher","first-page":"H441","DOI":"10.1152\/ajpheart.00590.2023","volume":"326","author":"N Hegemann","year":"2024","unstructured":"Hegemann N, Barth L, D\u00f6ring Y, Voigt N, Grune J. Implications for neutrophils in cardiac arrhythmias. Am J Physiol Heart Circul Physiol. 2024;326(3):H441\u201358.","journal-title":"Am J Physiol Heart Circul Physiol"},{"issue":"5","key":"4367_CR84","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cgh.2016.10.011","volume":"15","author":"KF Flack","year":"2017","unstructured":"Flack KF, Desai J, Kolb JM, Chatterjee P, Wallentin LC, Ezekowitz M, et al. Major gastrointestinal bleeding often is caused by occult malignancy in patients receiving warfarin or dabigatran to prevent stroke and systemic embolism from atrial fibrillation. Clin Gastroenterol Hepatol. 2017;15(5):682\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"4367_CR85","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jamainternmed.2017.5512","volume":"177","author":"GS Haaland","year":"2017","unstructured":"Haaland GS, Falk RS, Straume O, Lorens JB. Association of warfarin use with lower overall cancer incidence among patients older than 50 years. JAMA Intern Med. 2017;177(12):1774\u201380.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"4367_CR86","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/cpt.2362","volume":"111","author":"AA Iftimi","year":"2022","unstructured":"Iftimi AA, Rodr\u00edguez-Bernal CL, Peir\u00f3 S, Bonanad S, Ferrero-Gregori A, Hurtado I, et al. Association of vitamin K and non-vitamin K oral anticoagulant use and cancer incidence in atrial fibrillation patients. Clin Pharmacol Ther. 2022;111(1):200\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"4367_CR87","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s13577-023-00899-2","volume":"36","author":"J Ding","year":"2023","unstructured":"Ding J, Cao Y, Qi C, Zong Z. Dysregulated microRNAs participate in the crosstalk between colorectal cancer and atrial fibrillation. Hum Cell. 2023;36(4):1336\u201342.","journal-title":"Hum Cell"},{"issue":"6","key":"4367_CR88","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/gastro\/goaa076","volume":"8","author":"YQ Hou","year":"2020","unstructured":"Hou YQ, Wang YY, Wang XC, Liu Y, Zhang CZ, Chen ZS, et al. Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro. Gastroenterol Rep Oxf. 2020;8(6):465\u201375.","journal-title":"Gastroenterol Rep Oxf"},{"key":"4367_CR89","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35:893\u2013911.","journal-title":"J Clin Oncol"},{"issue":"10","key":"4367_CR90","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/ph16101441","volume":"16","author":"MK Kashyap","year":"2023","unstructured":"Kashyap MK, Mangrulkar SV, Kushwaha S, Ved A, Kale MB, Wankhede NL, et al. Recent perspectives on cardiovascular toxicity associated with colorectal cancer drug therapy. Pharmaceuticals. 2023;16(10):1441.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"4367_CR91","first-page":"8","volume":"12","author":"G Deboever","year":"2013","unstructured":"Deboever G, Hiltrop N, Cool M, Lambrecht G. Alternative treatment options in colorectal cancer patients with 5\u2013fluorouracil- or capecitabine-induced cardiotoxicity. Clin Colorectal Cancer. 2013;12(1):8\u201314.","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"4367_CR92","first-page":"1","volume":"3","author":"G Joy","year":"2019","unstructured":"Joy G, Eissa H, Al Karoudi R, White SK. Fluorouracil-induced takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features. Eur Heart J. 2019;3(4):1\u20136.","journal-title":"Eur Heart J"},{"issue":"9","key":"4367_CR93","volume":"8","author":"MW Saif","year":"2016","unstructured":"Saif MW, Smith M, Maloney A. The first case of severe Takotsubo cardiomyopathy associated with 5-fluorouracil in a patient with abnormalities of both dihydropyrimidine dehydrogenase (DPYD) and thymidylate synthase (TYMS) genes. Cureus. 2016;8(9):e783.","journal-title":"Cureus"},{"issue":"6","key":"4367_CR94","first-page":"1","volume":"5","author":"V SHaH","year":"2025","unstructured":"Shah V, Panchal V, Shah A, Vyas B, Bhowmik S, Panchal I, et al. Exosomal miRNAs as biomarkers in predicting chemotherapy\u2011induced cardiotoxicity in patients with cancer (review). Med Int. 2025;5(6):1\u201313.","journal-title":"Med Int"},{"key":"4367_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12:339.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4367_CR96","first-page":"23","volume":"2","author":"MI Ehrlich","year":"2020","unstructured":"Ehrlich MI, Kaley K, Smith M, Saif MW. Safety and efficacy of s-MOX regimen in patients with colorectal cancer who developed cardiotoxicity following fluoropyrimidine administration: a case series. Arch Med Case Rep. 2020;2(1):23.","journal-title":"Arch Med Case Rep"},{"issue":"8041","key":"4367_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-024-08105-5","volume":"636","author":"SM Blum","year":"2024","unstructured":"Blum SM, Zlotoff DA, Smith NP, Kernin IJ, Ramesh S, Zubiri L, et al. Immune responses in checkpoint myocarditis across heart, blood and tumour. Nature. 2024;636(8041):215\u201323.","journal-title":"Nature"},{"issue":"5","key":"4367_CR98","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jcsm.12116","volume":"7","author":"V Musolino","year":"2016","unstructured":"Musolino V, Palus S, Tschirner A, Drescher C, Gliozzi M, Carresi C, et al. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation. J Cachexia Sarcopenia Muscle. 2016;7(5):555\u201366.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4367_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247753","volume":"13","author":"NE Davis","year":"2024","unstructured":"Davis NE, Prasitlumkum N, Tan NY. Atrial fibrillation and cancer: epidemiology, mechanisms, and management. J Clin Med. 2024;13:7753.","journal-title":"J Clin Med"},{"issue":"10","key":"4367_CR100","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93098","volume":"2","author":"JT Thackeray","year":"2017","unstructured":"Thackeray JT, Pietzsch S, Stapel B, Ricke-Hoch M, Lee CW, Bankstahl JP, et al. Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression. JCI Insight. 2017;2(10):e93098.","journal-title":"JCI Insight"},{"issue":"1","key":"4367_CR101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ehf2.12372","volume":"6","author":"V Musolino","year":"2018","unstructured":"Musolino V, Palus S, Latouche C, Gliozzi M, Bosco F, Scarano F, et al. Cardiac expression of neutrophil gelatinase\u2010associated lipocalin in a model of cancer cachexia\u2010induced cardiomyopathy. ESC Heart Fail. 2018;6(1):89\u201397.","journal-title":"ESC Heart Fail"},{"key":"4367_CR102","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.3390\/ijms22137106","volume":"13","author":"TC Garcia-Gardu\u00f1o","year":"2021","unstructured":"Garcia-Gardu\u00f1o TC, Padilla-Gutierrez JR, Cambr\u00f3n-Mora D, Valle Y. RAAS: a convergent player in ischemic heart failure and cancer. Int J Mol Sci. 2021;13:7106.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4367_CR103","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","volume":"138","author":"E Bertero","year":"2018","unstructured":"Bertero E, Canepa M, Maack C, Ameri P. Linking heart failure to cancer: background evidence and research perspectives. Circulation. 2018;138(7):735\u201342.","journal-title":"Circulation"},{"issue":"23","key":"4367_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313185","volume":"25","author":"A\u00c1 Moln\u00e1r","year":"2024","unstructured":"Moln\u00e1r A\u00c1, Birg\u00e9s K, Surman A, Merkely B. The complex connection between myocardial dysfunction and cancer beyond cardiotoxicity: shared risk factors and common molecular pathways. Int J Mol Sci. 2024;25(23):13185.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4367_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060857","volume":"18","author":"AM Zebrowska","year":"2025","unstructured":"Zebrowska AM, Borowiec A. Potential new applications of sodium\u2013glucose cotransporter-2 inhibitors across the continuum of cancer-related cardiovascular toxicity. Pharmaceuticals. 2025;18(6):857.","journal-title":"Pharmaceuticals"},{"issue":"6162","key":"4367_CR106","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342(6162):1094\u20138.","journal-title":"Science"},{"issue":"5","key":"4367_CR107","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCGEN.120.002969","volume":"13","author":"ZN Al-Hassnan","year":"2020","unstructured":"Al-Hassnan ZN, Almesned A, Tulbah S, Alakhfash A, Alhadeq F, Alruwaili N, et al. Categorized genetic analysis in childhood-onset cardiomyopathy. Circul Genom Precis Med. 2020;13(5):504\u201314.","journal-title":"Circul Genom Precis Med"},{"issue":"15","key":"4367_CR108","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-17-0682","volume":"77","author":"J Kondelin","year":"2017","unstructured":"Kondelin J, Gylfe AE, Lundgren S, Tanskanen T, Hamberg J, Aavikko M, et al. Comprehensive evaluation of protein coding mononucleotide microsatellites in microsatellite-unstable colorectal cancer. Can Res. 2017;77(15):4078\u201388.","journal-title":"Can Res"},{"issue":"22","key":"4367_CR109","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022479","volume":"10","author":"H Kaneko","year":"2021","unstructured":"Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, et al. Untreated hypertension and subsequent incidence of colorectal cancer: analysis of a nationwide epidemiological database. J Am Heart Assoc. 2021;10(22):e022479.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"4367_CR110","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cgh.2021.01.037","volume":"20","author":"DE O\u2019Sullivan","year":"2022","unstructured":"O'Sullivan DE, Sutherland RL, Town S, Chow K, Fan J, Forbes N, et al. Risk factors for early onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20(6):1229-1240.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4367_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111489","volume":"413","author":"K Jomova","year":"2025","unstructured":"Jomova K, Alomar SY, Valko R, Liska J, Nepovimova E, Kuca K, et al. Flavonoids and their role in oxidative stress, inflammation, and human diseases. Chem Biol Interact. 2025;413:111489.","journal-title":"Chem Biol Interact"},{"issue":"11","key":"4367_CR112","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/s41416-022-01975-4","volume":"127","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Song M, Chan AT, Meyerhardt JA, Willett WC, Giovannucci EL. Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study. Br J Cancer. 2022;127(11):1974\u201382.","journal-title":"Br J Cancer"},{"issue":"4","key":"4367_CR113","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.advnut.2023.05.010","volume":"14","author":"C Diaz","year":"2023","unstructured":"Diaz C, Rezende LFM, Sabag A, Lee DH, Ferrari G, Giovannucci EL, et al. Artificially sweetened beverages and health outcomes: an umbrella review. Adv Nutr. 2023;14(4):710\u20137.","journal-title":"Adv Nutr"},{"issue":"5","key":"4367_CR114","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ajcnut.2025.02.021","volume":"121","author":"AH Chu","year":"2025","unstructured":"Chu AH, Lin K, Croker H, Kefyalew S, Becerra-Tom\u00e1s N, Dossus L, et al. Dietary patterns and colorectal cancer risk: global cancer update programme (CUP global) systematic literature review. Am J Clin Nutr. 2025;121(5):999\u20131016.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"4367_CR115","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.clnu.2020.02.002","volume":"39","author":"H Tangestani","year":"2020","unstructured":"Tangestani H, Salari-Moghaddam A, Ghalandari H, Emamat H. Adherence to the dietary approaches to stop hypertension (DASH) dietary pattern reduces the risk of colorectal cancer: a systematic review and meta-analysis. Clin Nutr. 2020;39(10):2975\u201381.","journal-title":"Clin Nutr"},{"issue":"6","key":"4367_CR116","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/codi.16092","volume":"24","author":"L Lu","year":"2022","unstructured":"Lu L, Koo S, McPherson S, Hull MA, Rees CJ, Sharp L. Systematic review and meta-analysis: associations between metabolic syndrome and colorectal neoplasia outcomes. Colorectal Dis. 2022;24(6):681\u201394.","journal-title":"Colorectal Dis"},{"issue":"2","key":"4367_CR117","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/CM9.0000000000002507","volume":"136","author":"M Han","year":"2023","unstructured":"Han M, Wang H, Shi H, Zhu S, Yang S, Zhao G, et al. Association between atherogenic index of plasma and colorectal neoplasms in patients with hypertension. Chin Med J (Engl). 2023;136(2):221\u20133.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"4367_CR118","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejca.2010.10.002","volume":"47","author":"AL Hawkes","year":"2011","unstructured":"Hawkes AL, Lynch BM, Owen N, Aitken JF. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer. 2011;47(2):267\u201376.","journal-title":"Eur J Cancer"},{"key":"4367_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102326","volume":"103","author":"P Lombardi","year":"2022","unstructured":"Lombardi P, Rossini D, Crespi V, Germani MM, Bergamo F, Pietrantonio F, et al.\u00a0Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: an individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature. Cancer Treat Rev. 2022;103:102326.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"4367_CR120","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008037","volume":"12","author":"S Frentzas","year":"2024","unstructured":"Frentzas S, Austria Mislang AR, Lemech C, Nagrial A, Underhill C, Wang W, et al. Phase 1a dose escalation study of ivonescimab (AK112\/SMT112), an anti-PD-1\/VEGF-A bispecific antibody, in patients with advanced solid tumors. J Immunother Cancer. 2024;12(4):e008037.","journal-title":"J Immunother Cancer"},{"key":"4367_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112187","volume":"224","author":"Z Chen","year":"2025","unstructured":"Chen Z, Kharazmi E, Liang Q, Sundquist K, Sundquist J, Fallah M. Family history of diabetes mellitus and risk of colorectal cancer: a nationwide cohort study. Diabetes Res Clin Pract. 2025;224:112187.","journal-title":"Diabetes Res Clin Pract"},{"issue":"19","key":"4367_CR122","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3748\/wjg.v28.i19.2148","volume":"28","author":"J Dimberg","year":"2022","unstructured":"Dimberg J, Shamoun L, Landerholm K, W\u00e5gs\u00e4ter D. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer. World J Gastroenterol. 2022;28(19):2148\u201351.","journal-title":"World J Gastroenterol"},{"key":"4367_CR123","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2022.02.005","volume":"166","author":"N Christou","year":"2022","unstructured":"Christou N, Bergen ES, Canton C, Le Malicot K, Di Bartolomeo M, Galli F, et al. Impact of diabetes and metformin use on recurrence and outcome in stage II\u2013III colon cancer patients: a pooled analysis of three adjuvant trials. Eur J Cancer. 2022;166:100\u201311.","journal-title":"Eur J Cancer"},{"key":"4367_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115405","volume":"221","author":"M Shatila","year":"2025","unstructured":"Shatila M, Cruz CC, Lu L, Abdul-Baki K, Baerman E, Takigawa K, et al. The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor. Eur J Cancer. 2025;221:115405.","journal-title":"Eur J Cancer"},{"key":"4367_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101498","volume":"61","author":"LA Broadfield","year":"2022","unstructured":"Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, et al. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome. Mol Metab. 2022;61:101498.","journal-title":"Mol Metab"},{"key":"4367_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115263","volume":"165","author":"A Malaekeh-Nikouei","year":"2023","unstructured":"Malaekeh-Nikouei A, Shokri-Naei S, Karbasforoushan S, Bahari H, Baradaran Rahimi V, Heidari R, et al. Metformin beyond an anti-diabetic agent: a comprehensive and mechanistic review on its effects against natural and chemical toxins. Biomed Pharmacother. 2023;165:115263.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4367_CR127","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11154-021-09675-9","volume":"22","author":"KTK Lau","year":"2021","unstructured":"Lau KTK, Ng L, Wong JWH, Loong HHF, Chan WWL, Lee CH, et al. Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment: a review. Rev Endocr Metab Disord. 2021;22(4):1121\u201336.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"4367_CR128","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4093\/dmj.2022.0383","volume":"48","author":"SY Wang","year":"2024","unstructured":"Wang SY, Zhang WS, Jiang CQ, Jin YL, Zhu T, Zhu F, et al. Association of measures of glucose metabolism with colorectal cancer risk in older Chinese: a 13-year follow-up of the Guangzhou biobank cohort study\u2014cardiovascular disease substudy and meta-analysis. Diabetes Metab J. 2024;48(1):134\u201345.","journal-title":"Diabetes Metab J"},{"issue":"8","key":"4367_CR129","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/gutjnl-2023-331701","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Cheung KS, Tan JT, Mak LY, Lee CH, Chiang CL, et al. Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study. Gut. 2024;73(8):1313\u201320.","journal-title":"Gut"},{"issue":"24","key":"4367_CR130","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1002\/cncr.34975","volume":"129","author":"HY Hsu","year":"2023","unstructured":"Hsu HY, Chern YJ, Hsu MS, Yeh TL, Tsai MC, Jhuang JR, et al. Diabetic severity and oncological outcomes of colorectal cancer following curative resection: a population-based cohort study in Taiwan. Cancer. 2023;129(24):3928\u201337.","journal-title":"Cancer"},{"issue":"11","key":"4367_CR131","doi-asserted-by":"publisher","first-page":"e4448","DOI":"10.1210\/clinem\/dgab466","volume":"106","author":"H Itoh","year":"2021","unstructured":"Itoh H, Kaneko H, Okada A, Yano Y, Morita K, Seki H, et al. Fasting plasma glucose and incident colorectal cancer: analysis of a nationwide epidemiological database. J Clin Endocrinol Metab. 2021;106(11):e4448\u201358.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4367_CR132","doi-asserted-by":"publisher","first-page":"98688","DOI":"10.3748\/wjg.v31.i3.98688","volume":"31","author":"RY Guan","year":"2025","unstructured":"Guan RY, Wu JW, Yuan ZY, Liu ZY, Liu ZZ, Xiao ZC, et al. Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer. World J Gastroenterol. 2025;31(3):98688.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4367_CR133","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/1073858413514278","volume":"20","author":"JP Ip","year":"2014","unstructured":"Ip JP, Fu AK, Ip NY. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Neuroscientist. 2014;20(6):589\u201398.","journal-title":"Neuroscientist"},{"issue":"4","key":"4367_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040727","volume":"11","author":"YH Chang","year":"2022","unstructured":"Chang YH, Yang HJ, Chen HW, Hsiao CW, Hsieh YC, Chan YW, et al. Characterization of collapsin response mediator protein 2 in colorectal cancer progression in subjects with diabetic comorbidity. Cells. 2022;11(4):727.","journal-title":"Cells"},{"issue":"19","key":"4367_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/cells11192974","volume":"11","author":"R Kamaraj","year":"2022","unstructured":"Kamaraj R, Drastik M, Maixnerova J, Pavek P. Allosteric antagonism of the pregnane X receptor (PXR): current-state-of-the-art and prediction of novel allosteric sites. Cells. 2022;11(19):2974.","journal-title":"Cells"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04367-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:30Z","timestamp":1790164950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04367-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":135,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4367"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04367-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study, as it was based solely on publicly available datasets and did not involve human participants or animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used de-identified public datasets; no additional consent was required.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}